EQS News: Mainz Biomed news Petra Smeltzer Starke zur Markenbotschafterin | 18.09.24

Mainz Biomedical expert Petra Smeltzer Starke zur Markenbotschafterin

The strategic partner with the permanent leading consultants of the white houses who bring the product development of Mainz biomedical scaffolds and the bed definition of the early recognition to the market

BERKELEY, USA and MAINZ, Germany – September 18, 2024 – Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or “Unternehmen”), a molecular genetic diagnostic diagnosis, is one of the spezialist credit recognitions that can use the Ernennung of Petra Smeltzer Starke for the Unternehmen. In the function of Mainz Biomed at the Entwicklung und Durchführung van Aufklärungskampagnen unterstützen, een beddeutung der Früherkennung van Darmkrebs hervorzuheben.

„Wir heißen Petra als Markenbotschafterin herzlich in our own team will come. “I will be separated from the success of the market development process by developing the Darmkrebsfrüherkennungstests der next generation, for which the development study will be initiated by the end of 2025 plans,” commented Guido Baechler, Chief Executive Officer of Mainz Biomed.

Petra Smeltzer is very serious: “I am happy and very happy with Mainz Biomed’s work. The Unternehmen have established a new maßstäbe bei der Früherkennung von Darmkrebs and in particular bei der Rekennung von prekanzerösen Polypen.”

For more information, please visit Mainz Biomed’s official Investor Website at mainzbiomed.com/investors/

Follow us, one of the new positions:

LinkedIn
X (formerly Twitter)
Facebook

About Petra Smeltzer Starke

Petra Smeltzer Starkes Karriere began studying international mathematics, trade and diplomacy at the School of Economics in Prague, and continued with modeling finance. Trotz zahlreicher Erfolge in der Modebranche, schloss Starke sowohl ihr Grundals auch ihr Hauptstudium als annual best ab and zog in the Vereinigten Staaten, one of the Georgetown University Jura to study.

A strong war is the best time for the legal process and the fight in the international Anwaltskanzlei O’Melveny & Myers, LLP, as Anwältin, who has a politically distorted image with the Bush administration. The end of the war was Starke for the mountain walk of the President of Obama and a spear for the White House, where he was at war as General Counsel of the White House Council of Economic Advisors and Senior Advisor to the President. There is a big war going on for the American presidents and the prosperity for diplomatic financial institutions and how to develop an international network organization. With your expertise as a team, the overarching opinion of Biden on Harris, at the ethical Grundsätze and the Vermeidung of Interessenkonflikten.

About Mainz Biomed NV

Mainz Biomed has developed marketable molecular genetic diagnostics for life-threatening diseases. The company’s lead product is ColoAlert®, a cost-effective, non-invasive and unilateral early detection test for the diagnosis of intestinal cancer. ColoAlert® is being marketed in Europe and the United Arab Emirates. The company is conducting a clinical

Investigation into the FDA Zulassung in the US during. Mainz Biomed’s product candidates have been tested on PancAlert, a screening test of the Bauchspeicheldrüsenkrebs, on the multiplex-nachweis molecular genetic biomarker in stuhlproben with polymerase chain reaction (PCR) in real time. For more information, visit mainzbiomed.com or follow us on LinkedIn, Twitter and Facebooking.

For press inquiries please refer to:

MC Services AG
Anne Hennecke/Caroline Bergmann
+49 211 529252 20
[email protected]

For investor inquiries, please contact [email protected]

Future-oriented excursions

A single exclusion in the press conference is “zukunftsgericht Aussagen” in the sin of the “Safe Harbor”-best immunity for the Private Securities Litigation Reform Act of 1995. Zukunftsgericht Aussagen can be assumed by the verwendung of Wörtern with “antizipieren”, “glauben ”, “erwarten”, “schätzen”, “planen”, “forhersagen” und “projizieren” und Other American Ausdrücke, die zukünftige Ereignisse or Trends voorhersage or auf diese hindweisen können en die nicht Aussagen aufgrund von historical Facts since, were identified. These targeted mirrors reflect the active analysis of the best information and broader and underlying risks and ambiguities. From this perspective it is important to consider the options available to you. Building and outsourcing risks can occur as the tatsächlichen ergebnisse in the maß von de Erwartungen or Vorhersagen des Unternehmens unterscheiden. The following factors may include a different way of working, while the different aspects of the work are different, which are described in these specific examples: (i) the closer nature of the interactions between the souls and the soul; (ii) Änderungen bei den zuwendenden Gesetzen oder Richtlinien; (iii) the spread of the COVID-19 pandemic on the network and the activation or visibility of markets; and (iv) other risks and uncertainties described herein, including those described herein and those described in other news releases and other public documents filed with the Securities and Exchange Commission (the “SEC”) by the Company. were being discussed. See the information regarding these and other factors, the observations and projections of the internal processes that appeared in the completed SEC filings, one of the annual reports on Formblatt 20-F, published on April 8 2024. The Company’s disclosures to the SEC can be found on the SEC’s website at www.sec.gov for disclosure. If any of the press conferences are aimed at obtaining basic information, the Mainz Biomed action will only be on the date of the date work, and it will be resolved. Mainz Biomed has no representation, it is possible that new information is created, whether it is a writing or another article, that time is carried out according to time, as a result of new information, future developments or otherwise, or that is for the purpose of inheritance.